- Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide
-
Kanno T, Matsui H, Akizawa Y, Usui H, Shozu M
- KMID: 2431234
- J Gynecol Oncol.
- 2018 Nov;29(6):e89.
- doi: 10.3802/jgo.2018.29.e89
OBJECTIVE: Highly effective chemotherapy for patients with low-risk gestational trophoblastic neoplasia (GTN) is associated with almost a 100% cure rate. However, 20%–30% of patients treated with chemotherapy need to change... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
-
Mitsuhashi A, Habu Y, Kobayashi , Kawarai Y, Ishikawa H, Usui H, Shozu M
- KMID: 2458897
- J Gynecol Oncol.
- 2019 Nov;30(6):e90.
- doi: 10.3802/jgo.2019.30.e90
OBJECTIVE: The present study investigated long-term outcomes of medroxyprogesterone acetate (MPA) plus metformin therapy in terms of control of atypical endometrial hyperplasia (AEH) and endometrial cancer (EC), and post-treatment conception. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
